Fineline Cube

Follow:
14455 Articles
Policy / Regulatory

FDA Issues Warning Letter to Sichuan Deebio for cGMP Violations in API Manufacturing

CompanyDrug

Bayer Advances BAY3018250 into Phase II Trial Following Successful Phase I Completion

CompanyDrug

BMS Seeks FDA Priority Review for Krazati in Advanced Colorectal Cancer

CompanyDrug

WuXi ATU’s Philadelphia Facility Approved for Amtagvi Production Following FDA Nod

CompanyDeals

HitGen’s Vernalis Partners with Hox Therapeutics to Develop Novel Cancer Inhibitors

CompanyDrug

Merck’s Keytruda Under Priority Review for New Indication in Endometrial Carcinoma

CompanyDeals

Immune-Onc Therapeutics Partners with Roche for Phase Ib/II Study of IO-108 in Liver Cancer

CompanyDeals

Innovent Biologics Partners with ImmVirX to Launch Clinical Study Combining Tyvyt and IVX037

Company

Biogen Appoints Ding Weibo as Head of Asia-Pacific Region, Succeeding Francis Wan

CompanyDeals

Shenzhen Eureka Biotechnology Secures RMB 300 Million in Series B+ Funding for CGT Expansion

CompanyDrug

Mabwell Bioscience Receives FDA Green Light for B7-H3 Targeting ADC 7MW3711

CompanyDeals

BMS and Sichuan Biokin Commence Joint Development of EGFR/HER3-Targeted ADC